Biotechnology News

October 23, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will host a conference call on Thursday, November 6, 2014, at 4:30 p.m. ET. During the call, management will review the company's third quarter 2014 financial...

October 23, 2014

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq:INCY) announced today it will present at the Nomura BioPharma Conference on Thursday, November 6, 2014 at 1:15 p.m. (EST) in Boston. The presentation will be webcast live and can be...

October 23, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Quartet Medicine, a biotechnology company focused on the development of novel treatments for chronic pain and inflammation, today announced the company raised $17 million in a Series A financing.

October 23, 2014

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Vaxart, Inc., a privately held company developing vaccines that are administered by tablet rather than by injection, today announced that the company is accelerating its Ebola tablet vaccine program....

October 23, 2014

CHAPEL HILL, N.C.--(BUSINESS WIRE)--POZEN Inc. (NASDAQ: POZN), a pharmaceutical company committed to transforming medicine that transforms lives, today announced that it has received three patents from the United States Patent and Trademark...

October 23, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Idec (NASDAQ: BIIB) today announced that two leading neuroscientists have joined the company to advance its research in neurodegenerative diseases. Christopher Henderson, Ph.D., joins as vice president,...

October 23, 2014

SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ:CELG) reported net product sales of $1,957 million for the third quarter of 2014, a 19 percent increase from the same period in 2013. Third quarter total revenue increased 18 percent to $...

October 23, 2014

OMAHA, Neb.--(BUSINESS WIRE)--Transgenomic, Inc. (NASDAQ: TBIO), today announced that the company will hold its Third Quarter 2014 Financial Results and Business Update Conference Call on Thursday, October 30, 2014 at 8:30 AM ET. To participate...

October 23, 2014

ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) announced that it will host a conference call and webcast to report its third quarter 2014 financial results on Thursday, October 30 at 8:30 a.m. ET. To participate in the...

October 23, 2014

PORTLAND, Ore.--(BUSINESS WIRE)--Independent study shows Sedia’s HIV-1 LAg-Avidity test is the top performing incidence assay.
CEPHIA comparison of incidence tests demonstrates that Sedia assay has the lowest false recency rate.

October 23, 2014

CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion Reports Third Quarter 2014 Results

October 23, 2014

BASKING RIDGE, N.J.--(BUSINESS WIRE)--Preliminary results reported in Headache and Pain journal show effectiveness of electroCore's hand held non-invasive vagus nerve stimulation device, gammaCore

October 23, 2014

CHICAGO--(BUSINESS WIRE)--The University of Chicago Medicine is partnering with BroadcastMed Inc. to launch Learning at the Forefront, a new digital education platform for medical professionals.

October 23, 2014

LYON, France--(BUSINESS WIRE)--Regulatory News: ERYTECH (Paris:ERYP)(Euronext Paris: FR0011471135 - ERYP), the French biopharmaceutical company that develops innovative ‘tumor starvation’ treatments for acute leukemia and other oncology...

October 22, 2014

SYDNEY--(BUSINESS WIRE)--Auspherix , an early stage Australian anti-infectives company, has secured a further AU$1 million in a series A financing from Australia's MRCF

October 22, 2014

SAN JOSE, Calif.--(BUSINESS WIRE)--New Report Shows Improving Biopharmaceutical Contract Manufacturing Market.

October 22, 2014

SAN DIEGO--(BUSINESS WIRE)--Cytori Therapeutics, Inc. (NASDAQ: CYTX) has received notification from the FDA that Cytori has provided additional information sufficient to support continuation of enrollment in its ATHENA cardiovascular trials. The...

October 22, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the launch of its Mantra™ Quantitative Pathology Workstation with inForm® Image Analysis...

October 22, 2014

VANCOUVER, British Columbia--(BUSINESS WIRE)--Zymeworks Inc., a privately held biotherapeutics company focused on the development of best-in-class antibody and next generation protein-based therapeutics, today announced the close and over-...

October 22, 2014

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE: BAX) announced today that it will present at the 2014 Credit Suisse Healthcare Conference on Wednesday, November 12, 2014 at 10:00 a.m. (CT). The live webcast of Baxter’s...

October 22, 2014

ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced it has completed its acquisition of Civitas Therapeutics and obtained global rights to CVT-301, a Phase 3 treatment candidate for OFF episodes of Parkinson’s...

October 22, 2014

WATERTOWN, Mass.--(BUSINESS WIRE)--Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today announced the closing of its underwritten public offering of 4,542,500 shares of common stock at an offering price of $19.00 per share. The shares of common...

October 22, 2014

DUBLIN--(BUSINESS WIRE)--Alkermes plc (NASDAQ: ALKS) will host a conference call at 8:30 a.m. EDT (12:30 p.m. GMT) on Wednesday, Oct. 29, 2014, to discuss the company’s financial results for the third quarter of 2014. Management will review the...

October 22, 2014

LAKEWOOD, Colo.--(BUSINESS WIRE)--In response to public health concerns over chikungunya virus and dengue fever, Terumo BCT will file a submission with the FDA to allow expanded access use of the Mirasol PRT system.

October 22, 2014

WASHINGTON--(BUSINESS WIRE)--During the 2014 Pacific Rim Summit Plenary Program, CEOs, CSOs and industrial biotechn industry veterans will highlight achievements and offer insight into the quickly changing and expanding markets.

October 22, 2014

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Center for Predictive Medicine and Emerging Infectious Diseases Expands Biosafety Lab, Purchases Provantis SaaS

October 22, 2014

PITTSBURGH--(BUSINESS WIRE)--An Ohio judge ruled that TrueAllele® Casework is reliable under the Daubert admissibility standard. Judge Maureen Clancy also denied discovery of TrueAllele source code. The defendant Maurice Shaw accepted a guilty...

October 22, 2014

BOULDER, Colo.--(BUSINESS WIRE)--Clovis Oncology, Inc. (NASDAQ: CLVS) will announce its third quarter 2014 financial results on Thursday, November 6, 2014, after the close of the U.S. financial markets. Clovis’ senior management will host a...

October 22, 2014

THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics today announced its partnership with the National Multiple Sclerosis Society as a sponsor of the nonprofit’s Houston area Walk MS fundraisers for the fourth consecutive year.

October 22, 2014

DENVER--(BUSINESS WIRE)--CBSA has selected the finalists for the 2014 “Company of the Year” and “Rising Star” Awards, which they will present during the Annual Awards Dinner held on Thursday, November 6.

October 22, 2014

VIENNA--(BUSINESS WIRE)--Experts share their “real world” experience of treating people with Inflammatory Bowel Disease (IBD) with biosimilar anti-TNFα monoclonal antibody (mAb)

October 22, 2014

SALISBURY, England & BEIJING--(BUSINESS WIRE)--Enigma Diagnostics Ltd (Enigma), a global leader in molecular diagnostic point-of-care (PoC) infectious disease testing, and Beijing Leadman Biochemistry Co., Ltd. (Beijing Leadman) (SZSE:300289...

October 22, 2014

CONCORD, Calif.--(BUSINESS WIRE)--Cerus to announce third quarter results after market close on Tuesday, November 4, 2014; call with management at 4:15 pm Eastern time.

October 22, 2014

SEATTLE--(BUSINESS WIRE)--TapImmune, Inc. (OTCBB:TPIV), provides an update on the status of its PolyStartTM vaccine technology platform in light of recent global concerns regarding pandemic infections and emerging viral threats such as Ebola and...

October 22, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--GOOD START GENETICS PRESENTS NEW NEXT-GENERATION SCREENING APPROACH TO PREIMPLANTATION GENETIC SCREENING

October 22, 2014

NEW YORK--(BUSINESS WIRE)--Despite its being the second leading cause of death worldwide, 93% of Americans still do not recognize the global threat stroke poses and the warning signs associated with it, according to a new public opinion study...

October 22, 2014

CAMBRIDGE, Mass. & SHANGHAI--(BUSINESS WIRE)--Foundation Medicine, Inc. (NASDAQ:FMI) and WuXi PharmaTech (Cayman) Inc. (NYSE:WX) today announced a collaboration to offer Foundation Medicine’s comprehensive genomic profiling to...

October 22, 2014

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Theorem Clinical Research will present the webinar, “Adaptive Design in Early-Phase Oncology Trials — Best Practices for Conduct,” at 10 a.m. EST on Nov. 12.

October 22, 2014

DANBURY, Conn.--(BUSINESS WIRE)--IMS Health (NYSE:IMS) today announced that it has entered into an innovative collaboration with UCB to help deliver greater business insights and improved operations, leveraging IMS Health’s Nexxus™ Commercial...

October 22, 2014

MINNEAPOLIS--(BUSINESS WIRE)--The SEED Partners, based in Minneapolis, announced today that it recently acquired FLIVO — a patented, proprietary healthcare technology platform from ImmunoChemistry Technologies.

October 22, 2014

PARIS--(BUSINESS WIRE)--Researchers use ScreenCell® to enrich Breast Cancer CTC Biomarkers. Metastatic breast cancer has a high mutation rate. Current tests for EpCam biomarkers only might miss important positive results.

October 22, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Acceleron Pharma (NASDAQ:XLRN) to host and webcast an online educational seminar on chronic kidney disease mineral and bone disorder (CKD-MBD) with leading nephrologist Ravi Thadhani, M.D., M.P.H.

October 22, 2014

TEL AVIV, Israel--(BUSINESS WIRE)--Compugen Ltd. (NASDAQ: CGEN) today announced that the Company will host a conference call at 10:00 AM ET on Wednesday, October 29, 2014 to review third quarter 2014 results

October 22, 2014

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--INNOCRIN PHARMACEUTICALS, CREATED AS A SPIN-OUT OF THE PROSTATE CANCER PROGRAM FROM VIAMET PHARMACEUTICALS
WILL FOCUS ON CLINICAL DEVELOPMENT OF BEST IN CLASS THERAPEUTICS

October 22, 2014

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Gynesonics, Inc., a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, today announced it has received approval from the U.S. Food and...

October 22, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Idec Inc. (NASDAQ: BIIB) today reported third quarter 2014 results, including revenue of $2.5 billion, a 37% increase compared to the third quarter of 2013. Third quarter 2014 non-GAAP diluted earnings...

October 22, 2014

PARSIPPANY, N.J.--(BUSINESS WIRE)--The Medicines Company (NASDAQ:MDCO), a global biopharmaceutical company focused on saving lives, alleviating suffering, and contributing to the economics of healthcare by focusing on the world's leading acute/...

October 22, 2014

GOTHENBURG, Sweden--(BUSINESS WIRE)--Region Zealand, Denmark has opted for a thoroughly tested alarm solution from the leading supplier in this field, Ascom Wireless Solutions. Staff safety is top priority for new psychiatric hospital.

October 22, 2014

BANGKOK--(BUSINESS WIRE)--Phyathai 2 International Hospital’s Heart Center uses the latest techniques and technology for Aortic valve stenosis treatment, use the new hybrid operating theater, the first one in Thailand.